Rhythm Pharmaceuticals, Inc.
RYTMNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $6.12B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $74.50$122.20
- Volume (live)
- -
- Avg. volume (3M)
- 749.65K
Rhythm Pharmaceuticals (RYTM) Stock Price & Financial Analysis
Rhythm Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $88.56 - $90.44 |
|---|---|
| 52-Week High | $122.20 |
| 52-Week Low | $74.50 |
| Open | $90.44 |
| Volume (last close) | 536.98K |
| Average Volume (3M) | 749.65K |
| Revenue (TTM) | 239.92M |
|---|---|
| Net Income (TTM) | -205.35M |
| Free Cash Flow (TTM) | -106.30M |
| EPS (TTM) | −$3.05 |
| Profit Margin | -85.59% |
| Operating Margin | -83.62% |
| Return on Equity (ROE) | -94.50% |
| Debt to Equity | 0.02 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 6.12B |
|---|---|
| Shares Outstanding | 68.59M |
| Price to Sales (P/S) | 25.52 |
| Price to Book (P/B) | 28.18 |
| EV/EBITDA | -33.42 |
| 50-Day MA | $100.96 |
|---|---|
| 200-Day MA | $97.59 |
| 1-Year Change | −16.70% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Rhythm Pharmaceuticals at a Glance
As of the Oct 23, 2026 close, Rhythm Pharmaceuticals (RYTM) has a market capitalization of $6.12B. The stock trades at 25.5× sales. Over the trailing twelve months it lost $205.35M on revenue of $239.92M and burned $106.30M of free cash flow. Revenue grew 53.5% year over year.
As of its latest reported balance sheet, it holds $65.61M in cash and securities against $3.68M of debt, a net cash position of $61.93M.
Rhythm Pharmaceuticals does not currently pay a dividend.
The share price is down 16.7% over the past year. At $89.27 (the Oct 23, 2026 close) it sits within its 52-week range of $74.50 to $122.20, below its 200-day moving average of $97.59.
Based on 16 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $146.64, 64.3% above the Oct 23, 2026 close.
Frequently Asked Questions About Rhythm Pharmaceuticals
What is the current stock price for RYTM?
As of the Oct 23, 2026 close, RYTM stock trades at $89.27. The 52-week range is $74.50–$122.20, with a day range of $88.56–$90.44.
What is the P/E ratio for RYTM?
The P/E ratio (Price-to-Earnings) for RYTM is shown in the Key Statistics section. This valuation metric helps compare Rhythm Pharmaceuticals, Inc. to industry peers.
Does RYTM pay dividends?
Rhythm Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for RYTM?
Based on ratings from 16 professional analysts over the last 90 days, the consensus for RYTM is Buy. The average 12-month price target is $146.64, a 64.3% upside from the Oct 23, 2026 close of $89.27.
What is the market cap of RYTM?
As of the Oct 23, 2026 close, Rhythm Pharmaceuticals's market capitalization is $6.12B, classifying it as a mid-cap company. Rhythm Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.